GLB-2002

N/A

Report date: 2025/07/03 16:42:39

Base Information

Drug NameGLB-2002
Drug Alias NameAAV-8-pTHVE-002AAV8.pTHVE002GLB-2002
ClassificationCell and gene therapy > Gene therapy > Viral vector-based gene therapy > Adeno-associated virus vector
Mechanisms of ActionGene transferenceVascular endothelial growth factor A inhibitors
TargetsVascular endothelial growth factor A
Therapy Area/IndicationsMacular Degeneration
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesGeneLeap Biotechnology LLC
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesGeneLeap Biotechnology LLC
Active IndicationsN/A
Inactive IndicationsMacular Degeneration

Other Information

ATC CodeN/A
Related LinksN/A